Alpine Woods Capital Investors’s Biogen BIIB Stock Holding History

Alpine Woods Capital Investors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-700	Closed	-$211K	–	262
2018 Q4	$211K	Sell	700 -3	-0.4%	-$957	0.05%	241
2018 Q3	$248K	Buy	+703	New	+$242K	0.05%	217

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpine Woods Capital Investors's BIIB Position: Q1 2019 in Review

Alpine Woods Capital Investors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 700 shares — an estimated $211K sold.

Alpine Woods Capital Investors first reported a position in BIIB in Q3 2018 and held it in 2 quarters. The position peaked at $248K in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Alpine Woods Capital Investors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Alpine Woods Capital Investors sold 700 Biogen shares in Q1 2019, an estimated $211K.
Alpine Woods Capital Investors first reported a position in Biogen in Q3 2018 and held it in 2 quarters.
Alpine Woods Capital Investors's Biogen position peaked at $248K in Q3 2018.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2019, filed 6 May 2019.